Document Status

This document has been corrected

The high costs of anticancer therapies in the USA: challenges, opportunities and progress

Published Online: 2024-10-04

Journal: Nature Reviews Clinical Oncology•Publisher: Springer Science and Business Media LLC

Authors: Rahul K. Nayak•Shelley A. Jazowski•Stacie B. Dusetzina

This document has been corrected

The high costs of anticancer therapies in the USA: challenges, opportunities and progress

Published Online: 2024-10-04

Journal: Nature Reviews Clinical Oncology

Authors: Rahul K. Nayak•Shelley A. Jazowski•Stacie B. Dusetzina

NOW

2024-10-30•Correction

Author Correction: The high costs of anticancer therapies in the USA: challenges, opportunities and progress

10.1038/s41571-024-00958-z

* information provided by CrossRef

2024-10-30•Correction

10.1038/s41571-024-00958-z

* information provided by CrossRef

2024-10-04•Published